(Q72370429)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7805751%20AND%20SRC:MED&resulttype=core&format=json

26 October 2019

title

Interleukin-4 but not interleukin-10 inhibits the production of leukemia inhibitory factor by rheumatoid synovium and synoviocytes (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7805751%20AND%20SRC:MED&resulttype=core&format=json

26 October 2019

6

Banchereau J

1 reference

26 October 2019

Dechanet J

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7805751%20AND%20SRC:MED&resulttype=core&format=json

26 October 2019

Taupin JL

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7805751%20AND%20SRC:MED&resulttype=core&format=json

26 October 2019

Chomarat P

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7805751%20AND%20SRC:MED&resulttype=core&format=json

26 October 2019

Rissoan MC

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7805751%20AND%20SRC:MED&resulttype=core&format=json

26 October 2019

Moreau JF

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7805751%20AND%20SRC:MED&resulttype=core&format=json

26 October 2019

Miossec P

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7805751%20AND%20SRC:MED&resulttype=core&format=json

26 October 2019

publication date

1 December 1994

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7805751%20AND%20SRC:MED&resulttype=core&format=json

European Journal of Immunology

26 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7805751%20AND%20SRC:MED&resulttype=core&format=json

26 October 2019

volume

24

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7805751%20AND%20SRC:MED&resulttype=core&format=json

26 October 2019

issue

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7805751%20AND%20SRC:MED&resulttype=core&format=json

26 October 2019

page(s)

3222-3228

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7805751%20AND%20SRC:MED&resulttype=core&format=json

Leukaemia inhibitory factor is identical to the myeloid growth factor human interleukin for DA cells

26 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830241247

7 January 2021

Molecular cloning and expression of the human homologue of the murine gene encoding myeloid leukemia-inhibitory factor

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830241247

7 January 2021

Leukemia inhibitory factor: a biological perspective.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830241247

7 January 2021

Leukemia inhibitory factor--a puzzling polyfunctional regulator

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830241247

7 January 2021

Leukemia inhibitory factor (LIF): a growth factor with pleiotropic effects on bone biology

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830241247

7 January 2021

The effect of leukemia inhibitory factor on bone in vivo

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830241247

7 January 2021

Cytokine signal transduction

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830241247

7 January 2021

Rheumatoid arthritis. Pathophysiology and implications for therapy

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830241247

7 January 2021

The role of cytokines in the pathogenesis of rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830241247

7 January 2021

Leukemia inhibitory factor/differentiation-stimulating factor (LIF/D-factor): regulation of its production and possible roles in bone metabolism

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830241247

7 January 2021

Increased levels of leukemia inhibitory factor in synovial fluid from patients with rheumatoid arthritis and other inflammatory arthritides

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830241247

7 January 2021

Leukemia inhibitory factor is expressed in cartilage and synovium and can contribute to the pathogenesis of arthritis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830241247

7 January 2021

Production of leukemia inhibitory factor by human articular chondrocytes and cartilage in response to interleukin-1 and tumor necrosis factor alpha

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830241247

7 January 2021

Induction of cytokine expression by leukemia inhibitory factor

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830241247

7 January 2021

Differentiation-inducing factor purified from conditioned medium of mitogen-treated spleen cell cultures stimulates bone resorption

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830241247

7 January 2021

Potential antiinflammatory effects of interleukin 4: suppression of human monocyte tumor necrosis factor alpha, interleukin 1, and prostaglandin E2

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830241247

7 January 2021

Coordinated antiinflammatory effects of interleukin 4: interleukin 4 suppresses interleukin 1 production but up-regulates gene expression and synthesis of interleukin 1 receptor antagonist

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830241247

7 January 2021

Interleukin 4 inhibits polyclonal immunoglobulin secretion and cytokine production by peripheral blood mononuclear cells from rheumatoid arthritis patients

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830241247

7 January 2021

Inhibition of the production of proinflammatory cytokines and immunoglobulins by interleukin-4 in an ex vivo model of rheumatoid synovitis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830241247

7 January 2021

Immunoregulatory role of interleukin 10 in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830241247

7 January 2021

A recombinant extracellular domain of the human interleukin 4 receptor inhibits the biological effects of interleukin 4 on T and B lymphocytes

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830241247

7 January 2021

The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830241247

7 January 2021

Strategies of anti-cytokine monoclonal antibody development: immunoassay of IL-10 and IL-5 in clinical samples

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830241247

7 January 2021

Immunogenicity of HILDA/LIF either in a soluble or in a membrane anchored form expressed in vivo by recombinant vaccinia viruses

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830241247

7 January 2021

Production of human interleukin for DA cells (HILDA)/leukemia inhibitory factor (LIF) by activated monocytes

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830241247

7 January 2021

Tumor necrosis factor alpha stimulates production of leukemia inhibitory factor in human dermal fibroblast cultures

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830241247

7 January 2021

Identifiers

DOI

10.1002/EJI.1830241247

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7805751%20AND%20SRC:MED&resulttype=core&format=json

26 October 2019

1 reference